Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights

Host: Hallie Blevins, PhD While transthyretin amyloid cardiomyopathy (ATTR-CM) is often viewed solely as a disorder of protein misfolding, a new review published in the European Heart Journal presents it as a dynamic imbalance between amyloid production and clearance. Hear from Dr. Hallie Blevins as she reviews pivotal data on ATTR-CM's expanding therapeutic landscape.